CClinicalTrials.gg
Not yet recruitingNCT03192007Updated Sep 16, 2026

Multi-Parametric MRI for Renal Transplantation

An observational study in Renal Transplant Rejection, sponsored by University of Minnesota. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by University of Minnesota · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
140
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The goals of this study are:

  • To optimize and evaluate multiple kidney MRI methods; and
  • To investigate the potential of MRI in the assessment of transplant kidney functions; To achieve these goals, we will perform pilot MRI studies with kidney transplant patients. We will study if MRI can reflect different levels of kidney function. The investigators will also evaluate if MRI can differentiate causes for declining kidney function. Finally, the investigators will explore how MRI measures changes before and after medical treatment for worsening kidney function.

You may be invited for MRI exams with different exam options. An MRI exam may use either of two types of MRI machines at the center for magnetic resonance research (CMRR): the 3 Tesla (3T) scanner and the 7 Tesla (7T) scanner. You may also be invited for a multi-session exam. A description of the MRI exam types with different exam options and the types of multi-session exams is provided later in this document.

Read the detailed description

To achieve these goals, the investigators will perform pilot MRI studies with kidney transplant patients. The investigators will study if MRI can reflect different levels of kidney function. The investigators will also evaluate if MRI can differentiate causes for declining kidney function. Finally, the investigators will explore how MRI measures changes before and after medical treatment for worsening kidney function.

Subjects may be invited for MRI exams with different exam options. An MRI exam may use either of two types of MRI machines at the CMRR: the 3T scanner and the 7T scanner. Subjects may also be invited for a multi-session exam. A description of the MRI exam types with different exam options and the types of multi-session exams is provided later in this document.

02

Conditions studied

  • Renal Transplant Rejection
03

In context

Lead sponsor

University of Minnesota is the lead sponsor of 1,184 studies on the registry; 195 are open to participants now.

Of its 132 completed or terminated interventional studies of FDA-regulated products, 91 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The proposed studies are pilot studies to obtain preliminary data for the development of hypotheses and estimate the power for future large-scale studies. To accomplish the objectives of the proposed pilot studies, we will enroll a total of 140 renal transplant patients. Based on our previous experience, there will be about 20% patients who may withdraw after informed consent. Equal number of male and female subjects will be recruited for each patient group. In addition, the age of patients will be matched or ensured insignificant across the groups of the study objectives.

Inclusion criteria

  • Renal Transplant Recipients
  • Capable to consent
  • English speaking
  • For studies with patients with fast worsening renal function: An abrupt (within 48 h) reduction in kidney function currently defined as a percentage increase in serum creatinine of ≥50% (1.5-fold from baseline), or a reduction in urine output (documented oliguria of less than 0.5 mL/kg/h for more than 6 h).
  • For patients with recovered renal allograft function after therapy: renal allograft function as measured by glomerular filtration rate (eGRF) has been recovered and stabilized above a clinical acceptable level, such as 15 ml/min/1.73 mm2.

Exclusion criteria

Exclusion Criteria:

  • On dialysis due to renal allograft failure
  • Acute and chronic pulmonary disease
  • Pregnancy as reported in CMRR Safety Screen
  • Ferromagnetic implants
  • Any foreign metal objects in the body
  • History of shrapnel or shot gun injury
  • Cardiac pacemakers
  • Defibrillator
  • Neuronal stimulator
  • Magnetic aneurysm clip
  • Large tattoos on the abdomen or the brain and neck, as determined by CMRR Safety Officer
  • Hip replacement
  • Too large to fit in the magnet (BMI >= 40, approx.)
  • Severe claustrophobia
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
140 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with Stable Renal Function

    Patients will be given MRI

    Device: Magnetic Resonance Imaging

  • Patients with Worsening Renal Function due to complications

    MRI

    Device: Magnetic Resonance Imaging

Interventions

  • DeviceMagnetic Resonance Imaging

    Investigate anatomic and functional characteristics of transplant kidneys using MRI

    Also known as: MRI

06

What researchers measure

Primary outcomes

  1. Anatomic and functional MRI characteristics in transplant kidneys with stable renal function

    Investigate the correlations between anatomic and functional characteristics by MRI and the level of transplant renal function

    Time frame: Baseline

Secondary outcomes

  1. Anatomic and functional MRI characteristics of transplant kidneys with transplant complications

    Investigate the anatomic and functional MRI characteristics of transplant kidneys with transplant complications with comparisons with those from transplant kidneys having stable renal function

    Time frame: Baseline

07

Study locations

1 site
  • CMMR
    Minneapolis, Minnesota 55455, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03192007
Lead sponsor
University of Minnesota
Responsible party
Sponsor
First posted
Jun 19, 2017
Start date
Jul 1, 2027 (estimated)
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Sep 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion